UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Annals of oncology, 2001-11, Vol.12 (11), p.1631-1641

2001

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

Journal of clinical oncology, 1999-02, Vol.17 (2), p.685-696

1999

Volltextzugriff (PDF)

Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans

Critical care medicine, 1996-05, Vol.24 (5), p.756-764

1996

Volltextzugriff (PDF)

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1078-1087

2001

Volltextzugriff (PDF)

Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard

The oncologist (Dayton, Ohio), 2001-01, Vol.6 (1), p.81-91

2001

Volltextzugriff (PDF)

Effects of a Novel Hemoglobin-Based Oxygen Carrier on Percent Oxygen Saturation as Determined With Arterial Blood Gas Analysis and Pulse Oximetry

Annals of emergency medicine, 1996-02, Vol.27 (2), p.164-169

1996

Volltextzugriff (PDF)

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

The New England journal of medicine, 2000-09, Vol.343 (13), p.905-914

2000

Volltextzugriff (PDF)

Hemoglobin‐based oxygen carrier preserves submaximal exercise capacity in humans

Clinical pharmacology and therapeutics, 1995-10, Vol.58 (4), p.434-443

1995

Volltextzugriff (PDF)

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial

Clinical lung cancer, 2001-05, Vol.2 Suppl 2, p.S26-S33

2001

Volltextzugriff (PDF)

A double stopcock technique for repeated sampling of venous blood

Methods and findings in experimental and clinical pharmacology, 1992-09, Vol.14 (7), p.537

1992

Volltextzugriff (PDF)

Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects

The Journal of laboratory and clinical medicine, 1995-11, Vol.126 (5), p.444

1995

Volltextzugriff (PDF)

Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer

Journal of clinical oncology, 2002-03, Vol.20 (5), p.1182-1191

Rocha Lima, C. M. S.

2002

Volltextzugriff (PDF)

Lifibrol: A novel lipid-lowering drug for the therapy of hypercholesterolemia

Clinical pharmacology and therapeutics, 1995-01, Vol.57 (1), p.73-88

1995

Volltextzugriff (PDF)

N-[(.omega.-Amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity

Journal of medicinal chemistry, 1991-01, Vol.34 (1), p.308-315

1991

Volltextzugriff (PDF)

Phlebotomy of 500 or 750 milliliters of whole blood followed by isovolemic hemodilution or autologous transfusion yields similar hemodynamic, hematologic, and biochemical effects

The Journal of laboratory and clinical medicine, 1994-02, Vol.123 (2), p.290

1994

Volltextzugriff (PDF)

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

Cancer, 2002-10, Vol.95 (7), p.1520-1527

2002

Volltextzugriff (PDF)

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

The New England journal of medicine, 2000-09, Vol.343 (13), p.905

2000

Volltextzugriff (PDF)

Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group

Clinical pharmacology and therapeutics, 1995-01, Vol.57 (1), p.73-88

1995

Volltextzugriff (PDF)

Hemoglobin-based oxygen carrier preserves submaximal exercice capacity in humans

Clinical pharmacology and therapeutics, 1995, Vol.58 (4), p.434-443

1995

Volltextzugriff (PDF)

N([ω-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity

Journal of medicinal chemistry, 1991, Vol.34 (1), p.308-315

1991

Volltextzugriff (PDF)

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

The New England journal of medicine, 2009-02, Vol.360 (7), p.679-691

2009

Volltextzugriff (PDF)

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

Haematologica (Roma), 2011-02, Vol.96 (2), p.231-237

2011

Volltextzugriff (PDF)

Single versus dual antiplatelet therapy following peripheral arterial endovascular intervention for chronic limb threatening ischaemia: Retrospective cohort study

PloS one, 2020-06, Vol.15 (6), p.e0234271-e0234271

2020

Volltextzugriff (PDF)

Noroviruses subvert the core stress granule component G3BP1 to promote viral VPg-dependent translation

eLife, 2019-08, Vol.8

2019

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(70)
Humans
(66)
Biological And Medical Sciences
(49)
Medical Sciences
(46)
Female
(45)
Male
(39)
Middle Aged
(36)
Adult
(35)
Animals
(25)
Aged
(24)
Pharmacology. Drug Treatments
(20)
Oncology
(16)
General & Internal Medicine
(14)
Adolescent
(12)
Prospective Studies
(12)
Aged, 80 And Over
(11)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(11)
Biochemistry & Molecular Biology
(9)
Chemistry
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard

Effects of a Novel Hemoglobin-Based Oxygen Carrier on Percent Oxygen Saturation as Determined With Arterial Blood Gas Analysis and Pulse Oximetry

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Hemoglobin‐based oxygen carrier preserves submaximal exercise capacity in humans

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial

A double stopcock technique for repeated sampling of venous blood

Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects

Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer

Lifibrol: A novel lipid-lowering drug for the therapy of hypercholesterolemia

N-[(.omega.-Amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity

Phlebotomy of 500 or 750 milliliters of whole blood followed by isovolemic hemodilution or autologous transfusion yields similar hemodynamic, hematologic, and biochemical effects

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group

Hemoglobin-based oxygen carrier preserves submaximal exercice capacity in humans

N([ω-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

Single versus dual antiplatelet therapy following peripheral arterial endovascular intervention for chronic limb threatening ischaemia: Retrospective cohort study

Noroviruses subvert the core stress granule component G3BP1 to promote viral VPg-dependent translation

Germline mutations in RAD51D confer susceptibility to ovarian cancer

Suchergebnisse filtern